KTN's online platform helps you to make the connections you need

 

The Knowledge Transfer Network (KTN) has refreshed its online platform to intelligently connect you to relevant events, funding, thought pieces and specialist staff to help your business innovate and grow.

You can discover content using your area of interest, from Defence Security to transport; from space to health – all major UK economic sectors are covered. Once you have selected your interests, using our intelligent tagging system, we will then display rich and relevant content related to your area, often from surprising sources.

An example might be new satellite technology from the space sector that is applicable in the agri-food sector. KTN-UK.co.uk will help you form these unusual and valuable connections.

All content on the platform has been carefully curated by our team of innovation specialists – not by an automated algorithm – so you can be confident that KTN is connecting you to the most relevant cutting-edge information.

 

The move also marks a closer alignment with our main funder, Innovate UK , with the website branding making a clear visual link. Knowledge Transfer Network is Innovate UK's innovation network partner, and also works with other funders to provide innovation networking services and fulfil our mission to drive UK growth.

We link new ideas and opportunities with expertise, markets and finance through our network of businesses, universities, funders and investors. From agri-food to autonomous systems and from energy to design, KTN combines expertise in all sectors with the ability to cross boundaries. Connecting with KTN can lead to potential partners, horizon-expanding events and innovation insights relevant to your needs.

Visit our people pages to connect directly with expertise in your sector.

Visit the KTN refreshed online platfom here

Entries with tag biotechnology .

Newton Fund Institutional Links and Researcher Links workshops now open

THE JULY 2016 ROUND OF INSTITUTIONAL LINKS AND RESEARCHER LINKS WORKSHOPS AND TRAVEL GRANTS ARE NOW OPEN, AND CLOSE ON 19 SEPTEMBER. LINKS ARE AVAILABLE FURTHER DOWN THE PAGE. PLEASE NOTE THAT NOT ALL OF THE NEWTON FUND COUNTRIES ARE INCLUDED IN EACH CALL.   The Newton Fund promotes the economic development and welfare in partnering countries, through science and...
Read More About Newton Fund Institutional Links and Researcher Links workshops now open »

The future of biopharmaceutical formulation - making better products with novel approaches

KTN Biopharmaceutical Formulation Group The future of biopharmaceutical formulation - making better products with novel approaches UCL, London Thursday 7th July, 2016 The KTN’s Biopharmaceutical Formulation Group will meet on 7th July at an event hosted by the EPSRC Centre for Innovative Manufacturing at UCL. The event is an opportunity to hear from industry and academia in...
Read More About The future of biopharmaceutical formulation - making better products with novel approaches »

New company created to develop novel technology to treat diabetes

UK technology has potential to bring islet transplant therapy to thousands of patients with type 1 diabetes The Cell and Gene Therapy Catapult (CGT) and University of Aberdeen, UK, today announce the creation of Islexa, a new company developing a novel technology to produce laboratory grown islets, the organoids responsible for insulin production. The technology could bring the...
Read More About New company created to develop novel technology to treat diabetes »

Programming Inititative on Antimicrobial Resistance (JPIAMR) call now open

The Joint Programming Initiative on Antimicrobial Resistance (JPIAMR) has opened its 4th Joint Call “Call for Transnational Networks/Working Groups within the Joint Programming Inititative on Antimicrobial Resistance ” , in partnership with 8 European countries (Belgium, France, Germany, Netherlands, Norway, Spain, Sweden and the UK), and Canada. The call sets out to assemble...
Read More About Programming Inititative on Antimicrobial Resistance (JPIAMR) call now open »

EU Funding - Exploring the Opportunities

MediCity Scotland in conjunction with Enterprise Europe Scotland, the Digital Health & Medical Biotech Knowledge Transfer Networks invites you to: EU Funding Exploring the Opportunities Date & Time:  28th April 2016, 12.30 - 15.30  Location:  MediCity, Scotland Free to attend With up to €2.5million in funding, business support and mentoring...
Read More About EU Funding - Exploring the Opportunities »

Össur acquires Touch Bionics

Össur acquires Touch Bionics Össur have recently signed an agreement to acquire Touch Bionics Limited, a leading global provider of innovative upper limb prostheses and supporting services. Touch Bionics has over 120 employees with operations in Scotland, Germany, and the United States. In 2015, total sales amounted to GBP 15 million (USD 21 million) with an adjusted EBITDA of GBP 0.9...
Read More About Össur acquires Touch Bionics »

The Inaugural UK Regenerative Medicine Conference

The UK Regenerative Medicine Conference being held at  RIBA, London   on 20 and 21 September 2016 (with dinner on 20 September) will draw together leaders in the field from the UK and across the globe to present and discuss the latest advances in regenerative medicine. As capacity for this event will be limited, those interested in attending are asked to pre-register their...
Read More About The Inaugural UK Regenerative Medicine Conference »

Future Formulation Call Funded Projects

Following EPSRC's Future Formulation Call, seven projects have now been funded receiving £15 million across 9 institutions. Those projects funded include " Enabling rapid liquid and freeze-dried formulation design for the manufacture and delivery of novel biopharmaceuticals" (Manchester University) & " Enabling rapid liquid and freeze-dried formulation design for the manufacture and...
Read More About Future Formulation Call Funded Projects »

SPARK - Boot Camp

SPARK - Boot Camp at BioHub at Alderley Park From 17th May 2016 14:00 To 19th May 2016 17:30 An intense two and a half day programme suitable for anyone wishing to learn the tools and techniques to explore their own life science start-up business idea, or to stress test their current company product, services, and business model. It is not essential...
Read More About SPARK - Boot Camp »

Cellular Reprogramming and Culture of hiPSCs: a practical training course and UK Stem Cell Bank workshop on gene-editing

Cellular Reprogramming and Culture of hiPSCs: a practical training course and UK Stem Cell Bank workshop on gene-editing  23rd to 26th May 2016. This event brings together three successful training and workshop activities in stem cell technology:  Harvard Stem Cell Institute/UK Stem Cell Bank reprogramming training course (23rd May), EBiSC practical training course in iPSC...
Read More About Cellular Reprogramming and Culture of hiPSCs: a practical training course and UK Stem Cell Bank workshop on gene-editing »

Discuva: Leading The Global Medical Search For New Lifesaving Antibiotics

A pharmaceutical company supported by Innovate UK is leading the world in the search for vital new antibiotics to treat resistant bacteria. Cambridge-based Discuva was able to speed up its efforts to discover new antibiotics using its ground-breaking technology after winning £1.6 million from Innovate UK’s Biomedical Catalyst fund in 2012. Discuva uses high-throughput microbial...
Read More About Discuva: Leading The Global Medical Search For New Lifesaving Antibiotics »

Downstream Processing: From Cell to Column, Integrated Solutions for Rapid Bioprocessing of Biologics

Downstream Processing: From Cell to Column, Integrated Solutions for Rapid Bioprocessing of Biologics  When: November 2016, dates to be confirmed Where: Biochemical Engineering, University College London This course focuses on the biological product recovery stage and, through a series of lectures, case studies and pilot plant practical sessions, will enable you to: ...
Read More About Downstream Processing: From Cell to Column, Integrated Solutions for Rapid Bioprocessing of Biologics »

Industry taskforce launched to secure the future of manufacturing advanced therapy medicines in the UK

A new Advanced Therapy Manufacturing Taskforce has been launched by the Medicines Manufacturing Industry Partnership (MMIP) to secure the future of manufacturing advanced therapies in the UK. Co-chaired by Minister for Life Sciences George Freeman and Ian McCubbin, SVP North America, Japan & Global Pharma Supply, GlaxoSmithKline, the new taskforce will be working to...
Read More About Industry taskforce launched to secure the future of manufacturing advanced therapy medicines in the UK »

1st European Biotechnology Network Convention

The 1st European Biotechnology Network Convention will take place on 23-24 June 2016 in Brussels. With a strong focus on all aspects of scientific and business collaboration, the Convention will bring together members from European SMEs, large companies, research organisations, public and private funders and policy makers that impact the biotechnology sector. Sessions on day 1 include...
Read More About 1st European Biotechnology Network Convention »

Important Industry/Academia BBSRC engagement opportunities & bioscience for health highlight

Under on-going implementation of the BBSRC strategy for maintaining and improving engagement with industry, BBSRC would like to highlight their Collaborative Training Partnerships  call and some of their regular industry collaborative research, training and people movement schemes which operate throughout the year.  Collaborative Training Partnerships (CTPs) – closing date...
Read More About Important Industry/Academia BBSRC engagement opportunities & bioscience for health highlight »

Industrial Technologies Conference 2016

22 – 24 June 2016 | RAI Amsterdam Industrial Technologies 2016 is the largest networking conference in the field of new production technologies, materials, nanotechnology, biotechnology and digitalisation in Europe, with more than 1.250 high level delegates. Industrial Technologies 2016 is a three days conference with a wide variety of plenary and interactive sessions, inspiring keynote...
Read More About Industrial Technologies Conference 2016 »

Albumedix Announces Exclusive Commercialization Agreement with ThioLogics for its Proprietary Drug Conjugation Platform

Albumedix havd announced new data that supports an exclusive agreement with ThioLogics, a UCL Business (UCLB) company, to commercialize the next generation of stable albumin drug conjugates. The data demonstrates the serum stability advantages achieved by combining Albumedix's albumin-based drug delivery technology, Veltis®, with ThioLogics' site-specific Next Generation Maleimide (NGM)...
Read More About Albumedix Announces Exclusive Commercialization Agreement with ThioLogics for its Proprietary Drug Conjugation Platform »

Analytical Data Analysis for the Bioprocessing Industry

Analytical Data Analysis for the Bioprocessing Industry – MBI® Short Courses When: 25-28 April 2016 Where: CPI, Darlington The module explores risk based decision making for bioprocess analytics by considering why a measurement is being made and what it conveys with regard to product critical quality attributes. Expert lectures supported by a series of workshops and case studies...
Read More About Analytical Data Analysis for the Bioprocessing Industry »

TrakCel selected for EU CAR-T Cell Therapy Project

TrakCel Ltd., a leading provider of Clinical supply chain orchestration technology for Cell, Gene and Immunotherapies, today announced its selection as a key partner in CARAT, an EU-funded project to support the development of CAR T cell therapies. The CARAT (Chimeric Antigen Receptors (CARs) for Advanced Therapies) project aims to integrate innovative cell manufacturing tools and...
Read More About TrakCel selected for EU CAR-T Cell Therapy Project »

Declaration by the Pharmaceutical, Biotechnology and Diagnostics Industries on Combating Antimicrobial Resistance

On January 21, 2016, the Declaration by the Pharmaceutical, Biotechnology and Diagnostics Industries on Combating Antimicrobial Resistance was launched at an event at the World Economic Forum in Davos, Switzerland. This was drafted, agreed and signed by 85 companies and nine industry associations from across the global pharmaceutical, diagnostics and biotechnology industries in...
Read More About Declaration by the Pharmaceutical, Biotechnology and Diagnostics Industries on Combating Antimicrobial Resistance »

Shire to Combine with Baxalta, Creating the Global Leader in Rare Diseases

Combination creates leading global biotechnology company projected to deliver double-digit top-line growth with over $20 billion in annual revenues by 2020    • No. 1 platform in rare diseases expected to generate 65% of total annual revenues  • Multiple, durable billion-dollar franchises, each with best-in-class products  • Robust portfolio includes...
Read More About Shire to Combine with Baxalta, Creating the Global Leader in Rare Diseases »

Midatech signs licencing agreement with Emergex Vaccines

Midatech Pharma, the international specialty pharmaceutical company focused on developing and commercialising products in oncology and other therapeutic areas, have announced that the Company has entered into a licensing agreement with Emergex Vaccines Limited (“Emergex”), a private UK biotechnology company focused on infectious diseases utilising Midatech’s gold nanoparticle technology....
Read More About Midatech signs licencing agreement with Emergex Vaccines »

Supporting innovative SMEs in the healthcare biotechnology sector

The healthcare biotechnology sector offers huge business and commercial opportunities; however it also requires heavy and risky investments which are often lacking in Europe, hampering the development of the industry. The challenge includes either: a) Cell technologies in medical applications (all phase 1 and phase 2 deadlines in 2016 and 2017) Cell technologies include cell...
Read More About Supporting innovative SMEs in the healthcare biotechnology sector »

Abzena raises £20m for US takeover and R & D

Cambridge medical technology business Abzena has conditionally raised £20 million to fund an acquisition in the US and underpin R & D on existing and developing products. The UK-quoted group has agreed to buy The Chemistry Research Solution LLC (TCRS), based in Philadelphia. The deal is subject to certain closing conditions including completion of the £20m placing and targets cancer...
Read More About Abzena raises £20m for US takeover and R & D »

Bio-entrepreneur Boot Camp at BioHub

The next Bio-entrepreneur Boot Camp at BioHub will take place from the 12 th  – 14 th  January 2016.  This intense two and a half day programme is suitable for anyone wishing to learn the tools and techniques to explore their own life science start-up business idea, or to stress test their current company product, services, and business model.    It is...
Read More About Bio-entrepreneur Boot Camp at BioHub »
Showing 1 - 25 of 33 results.
Items per Page 25
of 2